NANJING, China, - Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China, announced today that it intends to release its 2009 first quarter results on Monday, May 18, 2009, after the market closes in the United States. Simcere's chief executive officer, Jinsheng Ren, and chief financial officer, Frank Zhigang Zhao, will host an earnings conference call to discuss the company's 2009 first quarter results on Tuesday, May 19, at 8 a.m. ET (Tuesday, May 19, at 8 p.m. Beijing/Hong Kong time).
To access the conference call, please dial:
United States toll-free dial-in number: +1.800.659.2056
International dial-in number: +1.617.614.2714
North China toll-free dial-in number: 10.800.152.1490
South China toll-free dial-in number: 10.800.130.0399
Hong Kong dial-in number: +852.3002.1672
Please ask to be connected to Simcere's Q1 2009 earnings call and provide the following passcode: 25770430. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at http://www.simcere.com .
Following the earnings conference call, an archive of the call will be available by dialing:
United States toll-free dial-in number: +1.888.286.8010
International dial-in number: +1.617.801.6888
The passcode for replay participants is: 21293840. The telephone replay also will be archived on the "Investor Relations" section of the company's web site for seven days following the earnings announcement.
No comments:
Post a Comment